Results 221 to 230 of about 11,407 (242)

Biosimilars in Dermatology

JAMA Dermatology, 2021
openaire   +2 more sources

The Disappointment of the Biosimilar

Journal of Law, Medicine & Ethics, 2018
openaire   +2 more sources

Biosimilars: Review of regulatory, manufacturing, analytical aspects and beyond

Microchemical Journal, 2021
Ratih Ratih, Mufarreh Asmari, Ahmed M Abdel-Megied   +2 more
exaly  

Biosimilars – Biosimilars: ja, aber

Aktuelle Rheumatologie, 2015
openaire   +1 more source

Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers

ESMO Open, 2016
Josep Tabernero, Alexandru Eniu, Jacek Jassem   +2 more
exaly  

Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice

Pharmacological Research, 2017
Cristina Scavone, Concetta Rafaniello, Liberato Berrino   +2 more
exaly  

Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars

Nature Reviews Drug Discovery, 2012
Steven A Berkowitz, John R Engen, Jeffrey R Mazzeo   +2 more
exaly  

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology

ESMO Open, 2019
Josep Tabernero, Fatima Cardoso
exaly  

Biosimilars in oncology: key role of nurses in patient education

Future Oncology, 2020
Cornelius F Waller, Adriano Friganovic
exaly  

Clinical and Regulatory Concerns of Biosimilars: A Review of Literature

International Journal of Environmental Research and Public Health, 2020
Vesa Halimi, Armond Daci, Zaheer-Ud-Din Babar   +2 more
exaly